These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31547771)

  • 1. Incomplete atypical femoral fractures after bisphosphonate use in postmenopausal women.
    Canbek U; Akgun U; Soylemez D; Canbek TD; Aydogan NH
    J Orthop Surg (Hong Kong); 2019; 27(3):2309499019875262. PubMed ID: 31547771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy.
    La Rocca Vieira R; Rosenberg ZS; Allison MB; Im SA; Babb J; Peck V
    AJR Am J Roentgenol; 2012 May; 198(5):1144-51. PubMed ID: 22528906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
    Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR
    J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the incidence of atypical femoral fractures and bisphosphonate therapy.
    Clout A; Narayanasamy N; Harris I
    J Orthop Surg (Hong Kong); 2016 Apr; 24(1):36-40. PubMed ID: 27122510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritis.
    Meinen R; Galli-Lysak I; Villiger PM; Aeberli D
    BMC Musculoskelet Disord; 2016 Aug; 17():324. PubMed ID: 27491286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-associated atypical subtrochanteric femur fractures in the older patient.
    Gopal GK; Tam KL; Krishnan SP; Maddern IL
    N Z Med J; 2014 Feb; 127(1389):81-5. PubMed ID: 24548959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting healing and progression of conservatively treated incomplete atypical femoral fractures: retrospective observational study.
    Png MA; Koh JSB; Mohan PC; Howe CY; Howe TS
    J Bone Miner Metab; 2023 Jan; 41(1):61-73. PubMed ID: 36371726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.
    Meier RP; Perneger TV; Stern R; Rizzoli R; Peter RE
    Arch Intern Med; 2012 Jun; 172(12):930-6. PubMed ID: 22732749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical femur fracture during bisphosphonate drug holiday: a case series.
    Lovy AJ; Koehler SM; Keswani A; Joseph D; Hasija R; Ghillani R
    Osteoporos Int; 2015 Jun; 26(6):1755-8. PubMed ID: 25832177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and associated factor of atypical periprosthetic femoral fracture after hip arthroplasty.
    Lee YK; Park CH; Kim KC; Hong SH; Ha YC; Koo KH
    Injury; 2018 Dec; 49(12):2264-2268. PubMed ID: 30245278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
    Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
    J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
    Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.
    Righetti M; Wach J; Desmarchelier R; Coury F
    Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
    Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].
    Soen S
    Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.
    Park-Wyllie LY; Mamdani MM; Juurlink DN; Hawker GA; Gunraj N; Austin PC; Whelan DB; Weiler PJ; Laupacis A
    JAMA; 2011 Feb; 305(8):783-9. PubMed ID: 21343577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
    Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
    Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
    Mashiba T
    Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.
    Morales-Santana S; Díez-Pérez A; Olmos JM; Nogués X; Sosa M; Díaz-Curiel M; Pérez-Castrillón JL; Pérez-Cano R; Torrijos A; Jodar E; Rio LD; Caeiro-Rey JR; Reyes-García R; García-Fontana B; González-Macías J; Muñoz-Torres M
    Maturitas; 2015 Dec; 82(4):402-10. PubMed ID: 26358930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical femoral fractures in long-term osteoporotic treatment with bisphosphonates].
    Thein R; Tenenbaum S; Chechick O; Hershkovitz O; Chechik A; Caspi I
    Harefuah; 2012 Sep; 151(9):532-6, 555. PubMed ID: 23367748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.